Mechanisms for the high fidelity of translesion synthesis by Y-family DNA polymerases in human cells

人类细胞中 Y 家族 DNA 聚合酶高保真度跨损伤合成的机制

基本信息

  • 批准号:
    10550540
  • 负责人:
  • 金额:
    $ 43.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-02-01 至 2027-11-30
  • 项目状态:
    未结题

项目摘要

ABSTRACT By promoting replication through DNA lesions, translesion synthesis (TLS) DNA polymerases (Pols) play a critical role in preventing chromosomal instability and protecting against tumorigenesis. Unlike replicative Pols, TLS Pols have less constrained active sties and they lack proofreading 3'→5' exonuclease activity. Consequently, purified TLS Pols synthesize DNA opposite DNA lesions with an extremely low fidelity. Despite this, TLS operates in a predominantly error-free manner in normal human cells (not derived from cancers), The overall objective in this project is to identify the cellular processes and mechanisms by which high fidelity is imposed upon TLS by the intrinsically highly error-prone Y-family Pols. Using a combination of genetic, cellular, biochemical, and structural approaches, we will address the following questions: (1) Do the Y-family Pols associate with other protein factors in a multiprotein ensemble and do these proteins have activities that elevate the fidelity of the TLS Pol? (2) What is the protein composition of the entire Y-family Pol ensemble for error-free TLS in human cells? (3) How is the fidelity of TLS modulated by the components of the multiprotein ensemble? (4) What are the molecular underpinnings of action mechanisms via which components of the multiprotein ensemble impose high fidelity on Y-family Pols? To pursue these questions, we have identified a number of protein factors that function in TLS specifically in conjunction with Y-family Pols; included among these proteins are WRN which possesses DNA helicase and 3'→5' exonuclease activities, and WRNIP1 which has a DNA dependent ATPase activity. How these activities contribute to the fidelity of TLS by Y-family Pols opposite different types of DNA lesions will be analyzed in extensive mutational studies that include genome wide sequencing. Using proximity labeling in which TurboID is fused to Polη, we will determine whether there are additional proteins that function in TLS in conjunction with Y-family Pols and whether activities in these proteins affect the fidelity of TLS by these Pols. In biochemical studies with the purified multiprotein ensemble of Polη or Polι, we will ascertain the roles of WRN 3'→5' exonuclease, WRN and WRNIP1 ATPase, and of any other newly identified activities in the high fidelity of TLS by these Pols opposite different types of DNA lesions. From cryo- EM studies with the purified multiprotein ensemble of Polη or Polι, we will determine mechanistically how the components of the multiprotein ensemble modulate the fidelity of these Y-family Pols opposite DNA lesions. Cumulatively, these studies will identify the components of the multiprotein Y-family TLS replicases which carry out high fidelity TLS in human cells. They will reveal the mechanisms by which the various components constrain Y-family Pols' active sites to restrain nucleotide (nt) misincorporation and how WRN's 3'→5' exonuclease activity is coordinated with the TLS Pol for the removal of misinserted nt. These studies will be paradigm shifting and will open new vistas of research into the mechanistic details of TLS Pols' fidelity and they will give impetus to further elaboration of the roles of TLS Pols in genome integrity.
摘要 通过促进DNA损伤的复制,跨损伤合成(TLS)DNA聚合酶(Pos)发挥了重要作用。 在防止染色体不稳定性和防止肿瘤发生中起关键作用。与复制型波尔不同, TLS Pol具有较少限制的活性位点,并且它们缺乏校正3 '→ 5'外切核酸酶活性。 因此,纯化的TLS Pol以极低的保真度合成与DNA损伤相对的DNA。尽管 TLS在正常人类细胞(不是来自癌症)中以主要无错误的方式运行, 本项目的总体目标是确定高保真度的细胞过程和机制, 由本质上高度易错的Y族Pol施加在TLS上。利用基因,细胞, 生物化学和结构的方法,我们将解决以下问题:(1)做Y-家族的Pos 与多蛋白质集合中的其他蛋白质因子相关联,这些蛋白质是否具有提高 TLS Pol的保真度?(2)什么是蛋白质组成的整个Y-家庭Pol合奏为无误 人类细胞中的TLS?(3)TLS的保真度是如何被多蛋白系综的组分所调节的? (4)作用机制的分子基础是什么? 集成使Y系列柱体具有高保真度?为了解决这些问题,我们确定了一些 在TLS中特异性与Y家族Pol结合起作用的蛋白质因子;包括在这些蛋白质中 具有DNA解旋酶和3 '→ 5'核酸外切酶活性的WRN和具有DNA解旋酶活性的WRNIP 1 依赖ATP酶活性。这些活动如何通过Y族Pol对TLS的保真度做出贡献, 不同类型的DNA损伤将在广泛的突变研究中进行分析,包括全基因组研究, 测序使用邻近标记,其中TurboID与Polη融合,我们将确定是否存在 在TLS中与Y家族Pol结合起作用的其他蛋白质,以及这些蛋白质中的活性是否 影响TLS的保真度。在用纯化的Polη或 Pol 1,我们将确定WRN 3 '→ 5'外切核酸酶,WRN和WRNIP 1 ATP酶,以及任何其他新的 通过这些Pol在TLS的高保真度中鉴定出与不同类型的DNA损伤相对的活性。从低温- 通过使用Polη或Polι的纯化多蛋白系综的EM研究,我们将从机理上确定 多蛋白系综的组分调节这些Y家族Pol相对于DNA损伤的保真度。 累积起来,这些研究将鉴定多蛋白Y家族TLS复制酶的组分, 在人体细胞中进行高保真度的TLS。它们将揭示各种成分 限制Y家族Pos的活性位点以抑制核苷酸(nt)的错误掺入以及WRN的3 '→ 5' 外切核酸酶活性与TLS Pol协调以去除错误插入的nt。这些研究报告将 范式转变,并将开辟新的前景的研究机制的细节TLS Pos的保真度,他们 将推动进一步阐述TLS Pol在基因组完整性中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LOUISE PRAKASH其他文献

LOUISE PRAKASH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LOUISE PRAKASH', 18)}}的其他基金

Structure and function of DNA polymerase lambda opposite DNA lesions which disrupt Watson-Crick base pairing
DNA 聚合酶 lambda 的结构和功能与破坏 Watson-Crick 碱基配对的 DNA 损伤相反
  • 批准号:
    10065004
  • 财政年份:
    2017
  • 资助金额:
    $ 43.18万
  • 项目类别:
Role of cohesin in lesion bypass in DNA damaged human cells
黏连蛋白在 DNA 损伤人类细胞病变旁路中的作用
  • 批准号:
    9025476
  • 财政年份:
    2014
  • 资助金额:
    $ 43.18万
  • 项目类别:
Role of cohesin in lesion bypass in DNA damaged human cells
黏连蛋白在 DNA 损伤人类细胞病变旁路中的作用
  • 批准号:
    8693330
  • 财政年份:
    2014
  • 资助金额:
    $ 43.18万
  • 项目类别:
Translesion DNA synthesis in humans
人类跨损伤 DNA 合成
  • 批准号:
    6796160
  • 财政年份:
    2003
  • 资助金额:
    $ 43.18万
  • 项目类别:
Translesion DNA synthesis in humans
人类跨损伤 DNA 合成
  • 批准号:
    7523137
  • 财政年份:
    2003
  • 资助金额:
    $ 43.18万
  • 项目类别:
Translesion DNA synthesis in humans
人类跨损伤 DNA 合成
  • 批准号:
    8049745
  • 财政年份:
    2003
  • 资助金额:
    $ 43.18万
  • 项目类别:
Translesion DNA synthesis
跨损伤DNA合成
  • 批准号:
    6669403
  • 财政年份:
    2003
  • 资助金额:
    $ 43.18万
  • 项目类别:
Translesion DNA synthesis in humans
人类跨损伤 DNA 合成
  • 批准号:
    7796574
  • 财政年份:
    2003
  • 资助金额:
    $ 43.18万
  • 项目类别:
Translesion DNA synthesis in humans
人类跨损伤 DNA 合成
  • 批准号:
    6896909
  • 财政年份:
    2003
  • 资助金额:
    $ 43.18万
  • 项目类别:
Translesion DNA synthesis in humans
人类跨损伤 DNA 合成
  • 批准号:
    8247016
  • 财政年份:
    2003
  • 资助金额:
    $ 43.18万
  • 项目类别:

相似海外基金

Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
  • 批准号:
    2334970
  • 财政年份:
    2024
  • 资助金额:
    $ 43.18万
  • 项目类别:
    Standard Grant
NSF-BSF: Towards a Molecular Understanding of Dynamic Active Sites in Advanced Alkaline Water Oxidation Catalysts
NSF-BSF:高级碱性水氧化催化剂动态活性位点的分子理解
  • 批准号:
    2400195
  • 财政年份:
    2024
  • 资助金额:
    $ 43.18万
  • 项目类别:
    Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
  • 批准号:
    2334969
  • 财政年份:
    2024
  • 资助金额:
    $ 43.18万
  • 项目类别:
    Standard Grant
Mechanochemical synthesis of nanocarbon and design of active sites for oxygen reducton/evolution reactions
纳米碳的机械化学合成和氧还原/演化反应活性位点的设计
  • 批准号:
    23K04919
  • 财政年份:
    2023
  • 资助金额:
    $ 43.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Creation of porous inorganic frameworks with controlled structure of metal active sites by the building block method.
通过积木法创建具有金属活性位点受控结构的多孔无机框架。
  • 批准号:
    22KJ2957
  • 财政年份:
    2023
  • 资助金额:
    $ 43.18万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Catalysis of Juxaposed Active Sites Created in Nanospaces and Their Applications
纳米空间中并置活性位点的催化及其应用
  • 批准号:
    23K04494
  • 财政年份:
    2023
  • 资助金额:
    $ 43.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Generation of carbon active sites by modifying the oxygen containing functional groups and structures of carbons for utilizing to various catalytic reactions.
通过修饰碳的含氧官能团和结构来产生碳活性位点,用于各种催化反应。
  • 批准号:
    23K13831
  • 财政年份:
    2023
  • 资助金额:
    $ 43.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
CAREER: CAS: Understanding the Chemistry of Palladium and Silyl Compounds to Design Catalyst Active Sites
职业:CAS:了解钯和甲硅烷基化合物的化学性质以设计催化剂活性位点
  • 批准号:
    2238379
  • 财政年份:
    2023
  • 资助金额:
    $ 43.18万
  • 项目类别:
    Continuing Grant
CAS: Collaborative Research: Tailoring the Distribution of Transient vs. Dynamic Active Sites in Solid-Acid Catalysts and Their Impacts on Chemical Conversions
CAS:合作研究:定制固体酸催化剂中瞬时活性位点与动态活性位点的分布及其对化学转化的影响
  • 批准号:
    2154399
  • 财政年份:
    2022
  • 资助金额:
    $ 43.18万
  • 项目类别:
    Standard Grant
Engineering of Active Sites in Heterogeneous Catalysts for Sustainable Chemical and Fuel Production.
用于可持续化学和燃料生产的多相催化剂活性位点工程。
  • 批准号:
    RGPIN-2019-06633
  • 财政年份:
    2022
  • 资助金额:
    $ 43.18万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了